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Summary 
Using the plaque assay or the CPE test (cytopathogenic effect), we investigated 
the action of human, simian (rhesus), bovine and murine interferons on bovine 
rotavirus adapted to grow on established Rhesus monkey kidney cell line (MA 104) 
or Georgia Bovine Kidney cell line (GBK). Except for the murine interferon we 
used, which had no antiviral effect at all, the different interferons tested were 
clearly active. 
Three strains of bovine rotavirus were used: a canadian strain PQ (kindly 
furnished by Dr. M. E. B6gin, St-Hyacinthe, Qudbec) and strains St4 and $77 
isolated in our laboratory. They were grown on MA104 and GBK cells (1). Vesic- 
ular Stomatitis Virus (VSV), originally obtained from Dr. Youngner (Pittsburgh), 
was produced in L929 cells. 
Human fibroblast interferon (Hu IFN~) was induced in FS4 cells of human 
foreskin fibroblasts by-poly inosinate-polycytidylate (poly I:C) as described by 
VIL6EK and HAVELL (8) and partially purified by ammonium sulfate precipitation 
and chromatography on Biogel P150 and CM Sephadex as described by K~mHT (3). 
The specific activity of the preparation used throughout this work was 1 × 106 
international units per mg of protein. 
Mouse fibroblast interferon (Mu IFN~) was induced in L929 cells by NDV 
virus (Newcastle Disease Virus, Koumaroff strain). The purification of this inter- 
feron was achieved according to the method described by PAUCI~ER and STANCEK 
(6). Its final specific activity was 1 × t06 international units per mg of protein. 
Simian interferon (Rhesus IFN) was induced in MA 104 cells by infecting them 
with NDV (Koumaroff strain). The crude interferon, treated at pH 2 for at least 
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five days, was used without further purification, after neutralization and clarifi- 
cation by centi~fugation. 
For the production of bovine interferon (Boy IFN), GBK cells were induced 
with NDV (Koumaroff strain) and treated as the simian interferon. 
The action of interferons on rotavi.rus was first tested on MA104 cells using 
the plaque assay described by MATSU~O et al. (5) and DAG~AIS et al. (2). The cells 
were established in an antivirat state by incubation with IFN at 37 ° C overnight 
before inoculation with the bovine rotavirus. Then, the inhibitions by in~erferons 
of the cytopathogenic effect provoked either by VSV or by rotavirus were compared 
by the classical method using MA 104 and GBK cells. 
According to our results, human, simian and bovine interferons are active on 
bovine rotavirus grown in established Rhesus monkey kidney or Georgia bovine 
kidney celt lines, whereas one partially purified murine interferon is not active at 
all. Compared with VSV, bovine rotavirus does not appear to be less susceptible 
to bovine interferon as it was reported by La Bonnardi~re and coworkers (4). 
The choice of the experimental system is therefore important o ascribe the ef- 
ficiency of interferon against bovine rotavirus in defined conditions. As the data 
obtained with the three strains of rotavirus are similar, Table 1 gives the compari- 
son of the susceptibility to interferon of VSV and one strain of rota.virus. 
The antiviral activity was destroyed by a pretreatment with trypsin and cor- 
related well with the induction of 2'5' oligoisoadenytate synthetase (7). This 
indicates that interferon is the active factor involved in the antiviral effect. 
Our preliminary results show that human fibroblast interferon (Hu IFN ~) has 
an important heterologous antiviral effect in GBK cells infected with bovine 
rotavirus. I t  is therefore worthwhile to test the in vivo effect of human fibroblast 
interferon (Hu IFN~) on neonatal calf diarrhoea provoked by rotavirus. 
Table 1. Activity o/dij/erent inter/erons on ~A 104 and GBK cells on bovi~e rotavirus 
($77) and VSV multiplications 
Interferon 
Cell line Virus Hu IFN Rhesus IFN Boy IFN 
MA 104 VSV 1.00 1.00 1.00 
GBK VSV 1.17 t 1.7 0.68 
MAt04 ]=iota. S 77 t.39 1.39 3.76 
Figures represent the relative titer of the different interferons in the different systems 
used, compared to the titer obtained in MA 104 cells using VSV as challenge virus. The 
mean of two independent, determinations are used to establish the comparison. End- 
points of titration are read as 50 per cent protection against CPE with a technique 
involving 0.5 log10 dilution steps. Reprodueible data have been obtained using dilutions 
of interferon preparations titrating between 102 and 104 laboratory units/mI 
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